ACE2 and COVID-19: These findings underscore the dual protective effects of ACE2-Fc against both the direct cytotoxic consequences of SARS-CoV-2 infection and the associated inflammatory responses (Fig. 6), providing valuable insights into its potential as a therapeutic agent in managing COVID-19 by not only curbing viral entry but also attenuating the inflammatory sequelae of the infection.